The need to increase the easier access of patients with coronary arteries to the drugs “Favipiravir” and “Remedicio”

According to Webda, Dr. Saeed Namaki, Minister of Health, Treatment and Medical Education, in a letter addressed to Dr. Shanesaz, head of the Food and Drug Administration, emphasized: The use of antiviral drugs favipiravir and remediator to prevent mutations and resistance of the virus must comply with protocols. Prescriptions should also be prescribed by infectious and pulmonary physicians or general practitioners familiar with the protocols and approved by the university’s vice chancellors.
See the link below for more information

https://bit.ly/32fypRO

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

three × four =